The Role of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in the Treatment of Heart Failure in Patients with Type 2 Diabetes Mellitus. (2022). Actual Problems of Medicine and Pharmacy, 3(1), 1-10. https://doi.org/10.52914/apmp.v3i1.42